Ballentine Partners’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Ballentine Partners’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-18,500	Closed	-$72K	–	388
2017 Q4	$72K	Sell	18,500 -6,501	-26%	-$27.8K	﹤0.01%	361
2017 Q3	$79K	Buy	25,001 +21,429	+600%	+$80.5K	﹤0.01%	390
2017 Q2	$113K	Buy	+3,572	New	+$14.6K	0.01%	377

Other funds holding CDMO

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bandera Partners New York $221M AUM 10.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SIC

Schwartz Investment Counsel Plymouth, Michigan $2.82B AUM 13.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Ballentine Partners's CDMO Position: Q1 2018 in Review

Ballentine Partners sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2018, closing a stake of 18,500 shares — an estimated $72K sold.

Ballentine Partners first reported a position in CDMO in Q2 2017 and held it in 3 quarters. The position peaked at $113K in Q2 2017. 70 funds tracked by Wall St. Rank hold CDMO as of Q1 2018.

Ballentine Partners reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Ballentine Partners sold 18,500 Avid Bioservices, Inc. Common Stock shares in Q1 2018, an estimated $72K.
Ballentine Partners first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2017 and held it in 3 quarters.
Ballentine Partners's Avid Bioservices, Inc. Common Stock position peaked at $113K in Q2 2017.
70 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2018.

Based on Ballentine Partners's 13F filing for Q1 2018, filed 26 Apr 2018.